For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...
The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.
Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in DME Published in peer-reviewed journal Translational ...
The Brighterside of News on MSN2d
New eye drops successfully treat age-related macular degenerationToll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...
SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects ...
Citi has initiated coverage of EyePoint (EYPT) with a buy rating, stating it sees the company's drug Duravyu as well-positioned to compete in the wAMD market. Read more here.
LAS VEGAS and NEW YORK, Jan. 6, 2025 /PRNewswire/ -- SolidddVision™ smartglasses, the first true vision correction for people ...
An announcement from Opthea Limited ( (AU:OPT) ) is now available.
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Rates of nearsightedness, or myopia, are skyrocketing in kids—and scientists say it has to do with how little time they’re ...
Lenvatinib is under clinical development by AiViva BioPharma and currently in Phase II for Diabetic Macular Edema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback